The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

10 Jun 2020 11:06

RNS Number : 5450P
IMI PLC
10 June 2020
 

10 June 2020

IMI plc(the "Company")

Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Persons Closely Associated with them

This notification relates to transactions notified in accordance with the Market Abuse Regulation, further details below:

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

1. Massimo Grassi

2. Jun Hu

3. Daniel Shook

4. Roy Twite

2.

Reason for the notification

a)

Position/status

1. Divisional Managing Director

2. Divisional Managing Director

3. Chief Financial Officer

4. Chief Executive Officer

b)

Initial notification/ Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IMI plc

b)

LEI

2138002W9Q21PF751R30

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary share GB00BGLP8L22

b)

Nature of the transaction

Shares purchased pursuant to participation in the IMI Employee Share Ownership Plan

 c)

Price(s) and volume(s)

Price(s)

Volume(s)

1. £9.50

2. £9.50

3. £9.50

4. £9.50

16

16

13

13

d)

Aggregated information

· Aggregated volume

· Price

N/A Single transaction

e)

Date of the transaction

9 June 2020

f)

Place of the transaction

London Stock Exchange Main Market (XLON)

 

For further information, please contact:

John O'SheaGroup Legal Director and Company SecretaryTelephone: 0121 717 3700

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHSFIFSSESSESM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.